A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma.

Cancer Chemother Pharmacol. 2009 Jul;64(2):379-84.

Rubio JC1, Vázquez S, Vázquez F, Amenedo M, Fírvida JL, Mel JR, Huidobro G, Alvarez E, Lázaro M, Alonso G, Fernández I; Galician Group of Lung Cancer (GGCP in the Spanish acronym).

Rubio JC1 et al.
Ver